Page 41 - Hospital Authority Annual Report 2019-2020

nurses with expanded roles and responsibilities to manage 等新護理模式，為慢性病及多種疾病患者提
patients suffering from chronic diseases and co-morbidities via 供高質素的社康護理服務。由偶發性疾病護
Community Nursing Centres and virtual wards. From episodic 理到個案管理，新護理模式均有助提升病人
care to case management, patients were empowered to identify 的自我照顧能力，及早識別和處理健康問題。
and manage their health problems earlier.

Community-based services enable ongoing care and support for 以社區為本的服務能夠為病人提供持續的護
patients. HA enhanced the multidisciplinary support for patients 理。醫管局在港島西聯網提供額外的老人精
living in Residential Care Homes for the Elderly with the 神科外展服務人次，進一步加強對居於安老
provision of additional psychogeriatric outreach attendances. 院舍的長者的跨專業支援。我們繼續與食物
We continued the Student Mental Health Support Pilot Scheme, 及衞生局、教育局及社會福利署合作推行
in collaboration with the Food and Health Bureau, Education 「醫教社同心協作計劃」，更多學校參與為有
Bureau and Social Welfare Department, with extended coverage 精神健康需要的學生提供支援服務。同時，
to more schools to support students with mental health needs. 我們在多個聯網加強支援兒童及青少年精神
Support to multidisciplinary child and adolescent psychiatric
teams in various clusters was also strengthened. 科的跨專業醫療團隊。

To improve obstetric care, HA provided maternal special 為改善產科護理，醫管局在多間醫院待產病
care beds in the labour wards at a number of hospitals, and 房提供產婦特別護理病床，並為護理人員
offered training in high-risk pregnancy care to nursing staff. 提供照顧高危妊娠的訓練。同時，我們在
Meanwhile, in support of HA’s policy of promoting breastfeeding 港島東、港島西、九龍中及新界西聯網強化
for newborn babies in HA hospitals, the breastfeeding support 母乳餵哺支援團隊，以配合在公立醫院推廣
teams in Hong Kong East Cluster, Hong Kong West Cluster, 初生嬰兒母乳餵哺的政策。
Kowloon Central Cluster and New Territories West Cluster were
strengthened.

The scope of the HA Drug Formulary was widened to cover 醫管局繼續擴大《醫管局藥物名冊》以涵蓋
more drugs with accumulated scientific evidence on clinical 更多具實證療效的藥物。八種獲安全網資助
efficacy. Eight self-financed drugs with safety net coverage were 的自費藥物改列為專用藥物，並擴闊11種專
repositioned as special drugs in the HA Drug Formulary, while 用藥物的臨床應用範圍，用以治療糖尿病、
the therapeutic application of eleven special drugs classes 癌症、多發性硬化症、骨質疏鬆症、肝炎、
were expanded for management of diabetes mellitus, cancers, 結節性硬化症、精神病、心血管病、肺病和
multiple sclerosis, osteoporosis, hepatitis, tuberous sclerosis 腎病。
complex, psychiatric, cardiovascular, pulmonary and renal
diseases.

Head Office and Cluster Reports 總辦事處及醫院聯網工作匯報 39